Quest PharmaTech Inc. (TSXV:QPT)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Oct 20, 2026, 12:03 PM EST
Quest PharmaTech Balance Sheet
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash & Equivalents | 0.08 | 0.01 | 0.21 | 0.72 | 0.37 | 0.26 |
Cash & Short-Term Investments | 0.08 | 0.01 | 0.21 | 0.72 | 0.37 | 0.26 |
Cash Growth | -11.15% | -93.00% | -71.39% | 91.36% | 41.73% | 32.76% |
Other Receivables | - | - | - | 0.1 | 0.22 | 0 |
Receivables | - | - | - | 0.1 | 0.22 | 0 |
Prepaid Expenses | 0 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 |
Other Current Assets | - | -0 | - | - | - | - |
Total Current Assets | 0.09 | 0.03 | 0.23 | 0.84 | 0.62 | 0.29 |
Property, Plant & Equipment | - | - | - | - | 0 | 0.02 |
Long-Term Investments | 28.2 | 27.72 | 22.33 | 23.63 | 26.17 | 90.71 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Assets | 28.29 | 27.75 | 22.56 | 24.48 | 26.8 | 91.03 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Accounts Payable | 0.39 | 0.24 | 0.1 | 0.28 | 0.08 | 0.11 |
Accrued Expenses | 0.09 | 0.08 | 0.06 | 0.04 | 0.03 | - |
Short-Term Debt | 1 | 1 | 1 | 1 | 1 | 0.5 |
Current Portion of Leases | - | - | - | - | - | 0.01 |
Total Current Liabilities | 1.49 | 1.33 | 1.17 | 1.32 | 1.11 | 0.62 |
Total Liabilities | 1.49 | 1.33 | 1.17 | 1.32 | 1.11 | 0.62 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Common Stock | 30.74 | 30.74 | 30.74 | 30.74 | 30.74 | 30.62 |
Additional Paid-In Capital | 11.77 | 11.77 | 11.69 | 11.6 | 11.13 | 11.06 |
Retained Earnings | -15.5 | -15.88 | -20.88 | -19.08 | -16.06 | 48.78 |
Comprehensive Income & Other | -0.2 | -0.2 | -0.15 | -0.11 | -0.11 | -0.05 |
Total Common Equity | 26.8 | 26.43 | 21.4 | 23.15 | 25.7 | 90.41 |
Shareholders' Equity | 26.8 | 26.43 | 21.4 | 23.15 | 25.7 | 90.41 |
Total Liabilities & Equity | 28.29 | 27.75 | 22.56 | 24.48 | 26.8 | 91.03 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Total Debt | 1 | 1 | 1 | 1 | 1 | 0.51 |
Net Cash (Debt) | -0.92 | -0.99 | -0.79 | -0.28 | -0.63 | -0.25 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 169.13 | 169.13 | 169.13 | 169.13 | 169.13 | 168.24 |
Total Common Shares Outstanding | 169.13 | 169.13 | 169.13 | 169.13 | 169.13 | 168.24 |
Working Capital | -1.4 | -1.3 | -0.94 | -0.49 | -0.48 | -0.33 |
Book Value Per Share | 0.16 | 0.16 | 0.13 | 0.14 | 0.15 | 0.54 |
Tangible Book Value | 26.8 | 26.43 | 21.4 | 23.15 | 25.7 | 90.41 |
Tangible Book Value Per Share | 0.16 | 0.16 | 0.13 | 0.14 | 0.15 | 0.54 |
Machinery | - | - | - | - | 0.55 | 0.6 |
Leasehold Improvements | - | - | - | - | - | 0.01 |